Factory 99% Piperaquine Phosphate Powder CAS 4085-31-8 Chemical Intermediate

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A875
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Piperaquine Phosphate
• CAS: 4085-31-8
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 1g
• Function: Chemical Intermediate
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

 

Product Name	Piperaquine Phosphate
Appearance	White Powder
CAS NO.	4085-31-8
Storage	Keep in a cool, dry, dark location

 

Piperaquine Phosphate is a bis-quinoline antimalarial drug with the chemical formula and a specific CAS number of 85547-56-4. It is an important pharmaceutical compound used in the treatment and prevention of malaria.

 

1. Antimalarial Therapy: Piperaquine Phosphate is primarily used in combination with other antimalarial drugs, such as artemisinin derivatives, for the treatment of malaria, particularly in areas where resistance to other antimalarials is a concern.
2. Prophylactic Use: It can also be used for suppressive prophylaxis to prevent the occurrence of malaria symptoms in individuals at high risk of infection.
3. Research and Development: In the field of pharmaceutical research, Piperaquine Phosphate serves as a valuable tool for studying malaria parasite biology and drug resistance mechanisms.

1. Parasite Elimination: By interfering with the parasite's metabolic processes, Piperaquine Phosphate helps to eliminate malaria parasites from the bloodstream, thereby reducing the parasite load and alleviating symptoms.
2. Long-lasting Effect: It has a relatively long half-life, allowing for sustained therapeutic levels in the body and providing prolonged protection against malaria.
3. Combination Therapy: When used in combination with other antimalarials, Piperaquine Phosphate can enhance the overall efficacy of the treatment, reducing the risk of resistance development and improving patient outcomes.